Pfizer

Ex Pfizer CEO, CFO not to involve in Starboard's campaign on drugmaker

Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of its COVID products shrink

Activist investor Starboard Value acquires $1 billion stake in Pfizer

Read served as CEO until Albert Bourla took the position in 2019. Bourla was instrumental in working with BioNTech to develop a COVID-19 vaccine

Activist investor Starboard Value takes $1 billion stake in Pfizer

Starboard has also approached Ian Read, a former Pfizer CEO, and Frank D'Amelio, who served as CFO until 2021, and both have expressed interest in helping the activist investor

Pfizer to further reduce stake in Haleon, offers to sell 540 million share

The US company intends to sell 540 million Haleon shares, according to a statement on Monday

Pfizer surges 3% as investors cheer 350% dividend announcement; details

The northward movement in the rally follows the announcement of a whopping 350 per cent dividend, or Rs 35 per share, for FY24

GSK wins latest trial on cancer claims for heartburn drug Zantac: Official

The companies collectively are facing thousands of lawsuits against them in courts across the United States

Pfizer raises annual profit forecast on strong sales of cancer, heart drugs

The market for pharmaceutical products used in managing Covid-19 has shrunk by billions of dollars a year, including for Pfizer's vaccines and treatments

Tamil Nadu emerges as GCC magnet, pharma major AstraZeneca leads the charge

Not just AstraZeneca, but Pfizer and Roche have also set up their centres in the state

Pfizer, Moderna Covid vaccine patents battle to continue after UK ruling

Moderna had argued Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the Covid-19 pandemic began in late 2019

US' Kansas sues Pfizer for hiding Covid vaccine risks, making false claims

The lawsuit filed by Kansas, a US state, alleged that Pfizer promoted its vaccine's safety while hiding evidence linking it to pregnancy complications, such as miscarriages, and heart inflammations

Pfizer, AstraZeneca announce new investments of nearly $1 bn in France

Their investment pledges came as President Emmanuel Macron prepared to kick off on Monday the annual 'Choose France' event aimed at wooing big overseas businesses and investors

Pfizer reaches settlement in over 10,000 cancer lawsuits related to Zantac

Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to treat heartburn

Viagra trademark exclusive property of Pfizer, rules Delhi High Court

Delhi HC has ordered Renovision Exports to pay Pfizer Rs 3 lakh and issued a permanent injunction preventing the marketing of homoeopathic medicine under the 'VIGOURA' mark

GlaxoSmithKline sues Pfizer, BioNTech over Covid-19 vaccine technology

GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of COVID-19

Pfizer, Niper collaborate to support healthcare startups in India

The Pfizer INDovation initiative, which has supported 34 startups in India till now, is now expanding its reach through this collaboration with NIPER Ahmedabad

Pfizer agrees to pay $93 million to settle Lipitor antitrust lawsuit

Attorneys for Lipitor purchasers including Rochester Drug Co-Operative Inc and Puerto Rico's Drogueria Betances LLC disclosed the agreement in a filing on Wednesday in US court in Trenton, New Jersey

Pfizer agrees to pay $93 million to settle Lipitor drug antitrust lawsuit

Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market

Glenmark, Pfizer launch Abrocitinib in India for Atopic Dermatitis

The prevalence of atopic dermatitis in India has risen over the past three decades, with approximately 5.9 per cent of adults affected, of which 4.4 per cent suffer from a severe form of the disease

Pfizer posts surprise 4th quarter profit, but key products miss on sales

The New York-based drugmaker earned 10 cents per share on an adjusted basis for the fourth quarter. Analysts on average had expected a loss of 22 cents per share, according to LSEG data

Pfizer Q2 results: Net profit declines 52% at Rs 149 cr, revenue slips 9.8%

Drug firm Pfizer Ltd on Saturday reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023. The company had logged a net profit of Rs 311.07 crore in July-September period a year ago, according to a regulatory filing by Pfizer. Revenue from operations declined 9.76 per cent to Rs 575.21 crore in the quarter as against Rs 637.47 crore in the year-ago period. Total expense was at Rs 410.76 crore, down 5.66 per cent. Total income was at Rs 611.28 crore in September quarter 2023-24, down 7.62 per cent.